Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma

[1] Nakamura S(2003)Primary gastrointestinal lymphoma in Japan—a clinicopathologic analysis of 455 patients with special reference to its time trends Cancer 97 2462-2473

[2] Matsumoto T(2006)Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG) Leuk Lymphoma 47 2140-2146

[3] Iida M(2016)Gastrointestinal lymphoma in Southwest China: subtype distribution of 1,010 cases using the WHO (2008) classification in a single institution Acta Haematol 135 21-28

[4] Papaxoinis G(2014)Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up World J Gastroenterol 20 12993-13005

[5] Papageorgiou S(2014)Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity Blood Cancer J 4 7-3010

[6] Rontogianni D(2008)Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma Clin Cancer Res 14 3002-390

[7] Ding WS(2012)Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan Ann Hematol 91 383-1965

[8] Zhao S(2016)Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era Blood Cancer J 6 3-440

[9] Wang JC(2011)Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone Blood 117 1958-2442

[10] Vetro C(2008)Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma Histopathology 53 432-1729

[1] Nakamura S(2003)Primary gastrointestinal lymphoma in Japan—a clinicopathologic analysis of 455 patients with special reference to its time trends Cancer 97 2462-2473

[2] Matsumoto T(2006)Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG) Leuk Lymphoma 47 2140-2146

[3] Iida M(2016)Gastrointestinal lymphoma in Southwest China: subtype distribution of 1,010 cases using the WHO (2008) classification in a single institution Acta Haematol 135 21-28

[4] Papaxoinis G(2014)Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up World J Gastroenterol 20 12993-13005

[5] Papageorgiou S(2014)Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity Blood Cancer J 4 7-3010

[6] Rontogianni D(2008)Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma Clin Cancer Res 14 3002-390

[7] Ding WS(2012)Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan Ann Hematol 91 383-1965

[8] Zhao S(2016)Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era Blood Cancer J 6 3-440

[9] Wang JC(2011)Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone Blood 117 1958-2442

[10] Vetro C(2008)Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma Histopathology 53 432-1729